Luteolin can induce p53-mediated apoptosis regardless of oxaliplatin treatment and may eliminate oxaliplatin-resistant p53-null colorectal cells.

PMID:  Nutrients. 2019 Apr 2 ;11(4). Epub 2019 Apr 2. PMID: 30987009 Abstract Title:  Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells. Abstract:  Certain antioxidative flavonoids are known to activate nuclear factor E2-related factor 2 (Nrf2), a transcription factor that regulates cellular antioxidants and detoxifying response and …

These results provide insight into the mechanism that underlies the anticancer effects of luteolin on colon cancer.

PMID:  Exp Mol Med. 2019 Apr 15 ;51(4):40. Epub 2019 Apr 15. PMID: 30988303 Abstract Title:  Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Abstract:  Luteolin, a dietary flavone, modulates various signaling pathways involved in carcinogenesis. In this …

These findings illustrate that luteolin may be a potential drug for glioma treatment.

PMID:  Onco Targets Ther. 2019 ;12:2383-2396. Epub 2019 Mar 28. PMID: 30992674 Abstract Title:  Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma. Abstract:  Purpose: Glioma is a malignant tumor that originates in the brain and spine and is difficult to be completely removed. Though glioma patients receive active treatment, …

Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.

PMID:  Phytomedicine. 2019 Jun ;59:152774. Epub 2018 Nov 28. PMID: 31009852 Abstract Title:  Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Abstract:  BACKGROUND: Diabetes mellitus is a well-known risk factor for the development of heart failure. Inflammation and oxidative stress play a key role in the development of …

Luteolin successfully improved periodontal health in a ligature-induced experimental periodontitis.

PMID:  J Periodontol. 2019 May 22. Epub 2019 May 22. PMID: 31115905 Abstract Title:  The effect of luteolin in prevention of periodontal disease in Wistar rats. Abstract:  BACKGROUND: Periodontal disease is the chronic infectious disease of the periodontium. Because of irreversibility, prevention of disease is one of the most important goals of periodontal treatment. The …

Flavonoids showed anticancer effects on the ovarian cancer cells.

PMID:  Biomed Pharmacother. 2019 Aug ;116:109004. Epub 2019 May 22. PMID: 31128404 Abstract Title:  Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Abstract:  Flavonoids have been recently identified as a potential anticancer agent against various human epithelial cancers. In this study, the elucidation of …

Luteolin may provide a promising preclinical therapeutic line in multiple sclerosis being anti-inflammatory, antiapoptotic, and neurotrophic agent.

PMID:  IUBMB Life. 2019 Sep ;71(9):1401-1408. Epub 2019 Jun 11. PMID: 31185137 Abstract Title:  The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis. Abstract:  Multiple sclerosis (MS) is considered to be an autoimmune disorder of the central nervous system (CNS) manifested by chronic inflammation. Although its etiology …

Apigenin inhibits growth of the Plasmodium berghei and disrupts some metabolic pathways in mice.

PMID:  Phytother Res. 2018 Sep ;32(9):1795-1802. Epub 2018 May 11. PMID: 29748995 Abstract Title:  Apigenin inhibits growth of the Plasmodium berghei and disrupts some metabolic pathways in mice. Abstract:  Due to the challenges in the control, prevention, and eradication of parasitic diseases like malaria, there is an urgent need to discover new therapeutic agents. Plant-derived …

Co-administrating apigenin in a high-cholesterol diet prevents hypercholesterolaemia in golden hamsters.

PMID:  J Pharm Pharmacol. 2018 Sep ;70(9):1253-1261. Epub 2018 Jun 25. PMID: 29943490 Abstract Title:  Co-administrating apigenin in a high-cholesterol diet prevents hypercholesterolaemia in golden hamsters. Abstract:  OBJECTIVES: Hypercholesterolaemia is a major risk factor for developing atherosclerosis. Increased consumption of fruits and vegetables is recommended to hypercholesterolaemic patients. In this study, the hypocholesterolaemic effect of …

Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway.

PMID:  Biomed Pharmacother. 2018 Sep ;105:1283-1290. Epub 2018 Jun 22. PMID: 30021365 Abstract Title:  Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway. Abstract:  Chronic dietary high fructose leads to various kinds of undesirable metabolic effects. Apigenin, a naturally occurring plant flavone, is plentiful in fruits and vegetables. The aim of this study …

Design a site like this with WordPress.com
Get started